BRIEF-Newron: Zambon And Valeo Pharma Launch Onstryv For Parkinson’s disease In Canada

BRIEF-Newron: Zambon And Valeo Pharma Launch Onstryv For Parkinson’s disease In Canada
July 10 (Reuters) - Newron Pharmaceuticals SpA: * DGAP-NEWS: NEWRON’S COMMERCIALIZATION PARTNER ZAMBON AND VALEO PHARMA ANNOUNCE THE LAUNCH OF ONSTRYV(R) (SAFINAMIDE) FOR PARKINSON’S DISEASE IN CANADA ... read more
Source: Bing NewsPublished on 2019-07-10